University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Grand Rounds > HCV Infection
Management and Treatment of HCV Infection: Entering a New Era in 2011
greyline
transparent gif
transparent gif
Phyllis Tien
Back to CME Grand Rounds
Description
Presenter: Phyllis Tien, MD
Posttest
Video ClipWatch the Presentation Flash Icon View in FlashReal Icon View in Real
SlidesView Slides without Audio
Description
Dr. Phyllis Tien reviews recent studies of hepatitis C (HCV) management and treatment. She provides an overview of HCV therapy, highlighting its 2 primary goals of viral eradication and prevention of disease progression. She also describes the evolving range of agents available for treatment, including new direct-acting antiviral agents approved by the FDA.
Presenter: Phyllis Tien, MD

Dr. Tien is an Associate Professor in Medicine/Infectious Diseases at UCSF. She studies metabolic consequences of HCV and HIV infection, particularly insulin resistance, lipodystrophy, and hepatic steatosis in men and women.

Posttest
The activity consists of a slideshow accompanied by audio that can be viewed or browsed by all users. Following the slideshow presentation, users may complete a brief posttest to test their knowledge.